NantKwest Stock Price

-0.9899 (-6.6%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NantKwest Inc NK NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.9899 -6.6% 14.0001 13.45 15.338 14.79 14.99 14:46:55
Bid Price Ask Price Spread Spread % News
14.00 14.01 0.01 0.07% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
12,890 2,197,968 $ 14.31 $ 31,456,830 3,819,735 1.04 - 15.338
Last Trade Time Type Quantity Stock Price Currency
14:46:58 2 $ 14.0088 USD

NantKwest Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.50B 107.03M 37.01M $ 43.00k $ - -0.71 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

NantKwest News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week11.7715.33811.1713.412,458,1842.2318.95%
1 Month8.0715.3385.5810.154,165,9895.9373.48%
3 Months3.2015.3383.058.282,502,53310.80337.5%
6 Months3.7515.3382.527.192,156,22510.25273.34%
1 Year1.1415.3381.046.461,265,62412.861,128.08%
3 Years7.1915.3380.935.35634,9826.8194.72%
5 Years37.0038.480.937.25550,568-23.00-62.16%

NantKwest Description

NantKwest Inc is a United States-based firm functioning in the healthcare sector. It is focused on providing immunotherapeutic agents, especially natural killer cells to treat cancer, infectious and inflammatory diseases. Natural Killer (NK) cells are ancient cells in the human body designed to recognize and detect cells under stress or infected. The company's drug candidates such as activated NK cells, high-affinity NKs and target activated NK's address virally-induced cancers, viral, fungal and bacterial infections as well as critical diseases such as Ebola. Its pipeline product includes taNK, haNK, and aNK. Most of NatWest's sales are concentrated in the United States region although it has a reasonable market in Europe and other Non-U.S. territories.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.